Titlebook: Clinical Applications of Cytokines and Growth Factors; John R. Wingard (Professor of Medicine, Director), Book 1999 Springer Science+Busin

只看該作者 · 發(fā)表于 2025-3-27 09:17:16

Risk, Disaster and Crisis Reductionto poly-ethylene glycol to form PEG-rHuMGDF, results in a molecule that is approximately ten times more potent . than non-pegylated MGDF .. PEG-rHuMGDF has been chosen as the agent for clinical use. A full length gycosylated form of thrombopoietin, ., is also being developed.

只看該作者 · 發(fā)表于 2025-3-27 09:36:40

只看該作者 · 發(fā)表于 2025-3-27 15:22:11

只看該作者 · 發(fā)表于 2025-3-27 21:41:39

Clinical Studies of Thrombopoietinto poly-ethylene glycol to form PEG-rHuMGDF, results in a molecule that is approximately ten times more potent . than non-pegylated MGDF .. PEG-rHuMGDF has been chosen as the agent for clinical use. A full length gycosylated form of thrombopoietin, ., is also being developed.

只看該作者 · 發(fā)表于 2025-3-27 22:15:58

只看該作者 · 發(fā)表于 2025-3-28 02:35:07

The Interaction of Cytokines with Stem Cell and Stromal Cell Physiology(BM) play a central role in regulating haemopoiesis. Despite considerable research efforts, the precise molecular mechanisms responsible for this control remain to be fully defined. Nevertheless, from these studies has emerged the general consensus that at least two classes of molecules including ha

只看該作者 · 發(fā)表于 2025-3-28 08:12:45

只看該作者 · 發(fā)表于 2025-3-28 13:34:05

		自動(dòng)登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛(ài)論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點(diǎn)評(píng)	投稿經(jīng)驗(yàn)總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機(jī)版\|小黑屋\| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-29 14:49
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved